Resistance to chemotherapy, likely a consequence of the overexpression of anti-apoptotic BCL-2 family members – including MCL-1, along with a high rate of metastasis are common problems encountered in osteosarcoma patients [7]. This evidence concerns the gene BCL2 and osteosarcoma.